Target intelligence / Profile preview

Galanin type 3 receptor (GALR3)

Target
GALR3
Molecular classification
G protein-coupled receptor, Receptor, Class A GPCR
01

Overview

The galanin type 3 receptor (GALR3) is a G protein-coupled receptor (GPCR) that binds the neuropeptide galanin as well as spexin-1. It modulates a variety of physiological processes including cognition and memory, sensory/pain processing, hormone secretion, and feeding behavior. In the nervous system, it plays roles in immune and inflammatory response modulation, particularly relevant to retinal health and disease. Inhibition or genetic ablation of GALR3 has been shown to protect against retinal degeneration in animal models. It is broadly expressed throughout the nervous system, including high expression in the retina, locus coeruleus, dorsal raphe nucleus, and neuroblastoma tissues. It couples mainly to inhibitory G proteins (G\(_i\)/G\(_o\)), inhibiting adenylyl cyclase and decreasing cAMP.

02

Mechanism of action

G\(_i/o\)-mediated inhibition of adenylyl cyclase

03

Biological functions

Signal transductionCognition and memory modulationSensory/pain processing modulationHormone secretion modulationFeeding behavior modulationImmune response modulationInflammatory response modulationRetinal homeostasis maintenance
04

Disease associations

Retinal degenerationRetinopathiesDepressionNeuroblastoma
05

Interacting drugs

Galanin

9 more in the full profile.

Beyond the preview

Go deeper on Galanin type 3 receptor (GALR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galanin type 3 receptor (GALR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call